InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Sunday, 04/10/2022 3:02:08 PM

Sunday, April 10, 2022 3:02:08 PM

Post# of 16698
Almost No one posts here anymore. sadly true.
AGN's management,and their employees are doing the hard jobs attempting to produce 'stellar' results as a speculative pharma with the repurposed drug concept.
ON A MINIMAL Budget.
This is a Home Run or bust play for most as any speculative investment should be considered, IMO. (Some Trading at major events of course)
AGN has attracted Dr Strassman and other top names and medical institutions like Charles River Lab's and Hammerschmidt's involvement in the micro-dose / sub hallucinogenic use of DMT for the treatments of Strokes. The IP has been licensed and MOAs filed.
Dr. North is the consultant for the IP and MOAs involved with the Ifenprodil SCLC / Pancreatic Cancer Tumor treatments that has so far received support from the FDA.
Apparently, the trending from the IPF/CC clinical trial down under was strong enough to pursue full strength Cronic Cough clinical Trials.
AGN has again dug into the NASH re-purposed drug bag from Dr Mark Williams (merger) and is now pursuing CKD treatments. Dr Williams is on the BOD now.

I am holding AGN stock and may buy more depending on the winds. Cant see any reason to sell, especially now at this bottom created by the 'not stelar enough' results from our COVID trial, vaccines, BP and the share consolidation. Ouch,,, but there are new cards in play,,, with an IPO carrot,,, possibilities of a NASDAQ listing with success from any of the three THREE three paths. Financing at >$30+.?.$50.?.

I SEE THREE When/IF...?...GLTA...
This is SPECTOWN . .. My money, My responsibilities... GLTA...